Human Vaccines and Immunotherapeutics This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Editorial to special issue “The power of immunoprofiling supported by computational data integration and machine learning”
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 15, 2024 Category: Allergy & Immunology Authors: Elke Bergmann-LeitnerBiologics Research & Development, Center Infectious Disease Research, Walter Reed Army Institute of Research, Silver Spring, MD, USA Source Type: research
Real-world effectiveness of recombinant zoster vaccine in self-identified Chinese individuals aged ≥50 years in the United States
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 15, 2024 Category: Allergy & Immunology Authors: Ana FloreaLina SyLei QianBradley AckersonYi LuoJun WuYanjun ChengJennifer KuLeticia Vega DailyHarpreet TakharJeannie SongElizabeth Chmielewski-YeeO ’Mareen SpenceHarry SeifertDriss OraichiHung Fu Tsenga Department of Research and Evaluation, Kaiser Perm Source Type: research
Human vaccines and immunotherapeutics: News February 2024
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 13, 2024 Category: Allergy & Immunology Authors: Ronald EllisAdam Weissa Editor-in-Chief, Jerusalem, Israelb Acquisitions Editor, Taylor & Francis Group Source Type: research
Changes in vaccine coverage and incidence of acute gastroenteritis and severe rotavirus gastroenteritis in children < 5 years in Shibata City, Niigata Prefecture, Japan
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 13, 2024 Category: Allergy & Immunology Authors: Tomohiro OishiSatoshi HasegawaTokushi NakanoShoji SudoHiroaki KuwajimaShuko TokurikiTsutomu Tamuraa Department of Clinical Infectious Diseases, Kawasaki Medical School, Kurashiki, Okayama, Japanb Pediatric Department, Niigata Prefectural Shibata Hospital, Source Type: research
Unraveling the copper-death connection: Decoding COVID-19 ‘s immune landscape through advanced bioinformatics and machine learning approaches
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 12, 2024 Category: Allergy & Immunology Authors: Qi WangZhenzhong SuJing ZhangHe YanJie Zhanga Department of Respiratory and Critical Care Medicine, The Second Hospital of Jilin University, Changchun, Jilin, Chinab Department of General Gynecology, The First Hospital of Jilin University, Changchun, Jili Source Type: research
Immunogenicity of COVID-19 vaccines in patients with cirrhosis: A meta-analysis
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 11, 2024 Category: Allergy & Immunology Authors: Lichen OuyangGang LeiYeli Gonga Department of Immunology, School of Medicine, Jianghan University, Wuhan, Chinab Department of Obstetric, Centre Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, China Source Type: research
Protective doses of tetanus toxoid immunization and its associated factors among mothers in southern Ethiopia
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 11, 2024 Category: Allergy & Immunology Authors: Maycas GembeTeklu WosenyelehWubishet GezimuDepartment of Nursing, College of Health Science, Mattu University, Mattu, Ethiopia Source Type: research
Using an extended information-motivation-behavioral skills model to explain HPV vaccination intention among men who have sex with men only and men who have sex with men and women
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 11, 2024 Category: Allergy & Immunology Authors: Guiqian ShiBing LinHaiying PanWei HeXiaoni ZhongSchool of Public Health, Research Center for Medicine and Social Development, Chongqing Medical University, Chongqing, China Source Type: research
Using big data to analyze the vaccination status of children with congenital heart disease in Yinzhou District, China
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 11, 2024 Category: Allergy & Immunology Authors: Lin ZhangZiliang YangYueqi YinWenzan HuangTianfei YiJianming PingLiya LiuPeng ShenYexiang SunHongbo Lina Yinzhou District Center for Disease Control and Prevention, Ningbo, Zhejiang, Chinab Medical School, Department of Preventive Medicine, Ningbo Univers Source Type: research
Seroprevalence of tetanus and pertussis antibodies among health care workers in Wuhu, China
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 11, 2024 Category: Allergy & Immunology Authors: Wei ShiBingsong WangQinghong MengXianlai ZhangZhen LiFang HeFei YingLinyan CongKaihu Yaoa MOE Key Laboratory of Major Diseases in Children ,National Key Discipline of Pediatrics, National Clinical Research Center for Respiratory Diseases, Beijing Pediat Source Type: research
Enhanced passive safety surveillance of high-dose and standard-dose quadrivalent inactivated split-virion influenza vaccines in Germany and Finland during the 2022/23 influenza season
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 7, 2024 Category: Allergy & Immunology Authors: Marina Amaral de Avila MachadoSonja Gandhi-BangaSophie GalloTathyana Giannotti CousseauReddappa Maniganahally ByrareddyMarkku Nissil äJörg SchellingCeline Monfredoa Epidemiology & Benefit-Risk, Sanofi, Toronto, Canadab Medical Operations, Sanofi, Lyon, Source Type: research
The role of vaccine literacy and health literacy in the health prevention decision-making process
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 6, 2024 Category: Allergy & Immunology Authors: Claudia IsonneCarolina MarzuilloPaolo VillariValentina BaccoliniDepartment of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy Source Type: research
Factors influencing adverse events following COVID-19 vaccination
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 6, 2024 Category: Allergy & Immunology Authors: Paola VillanuevaEllie McDonaldJulio CrodaMariana Garcia CrodaMargareth DalcolmoGlauce dos SantosBruno JardimMarcus LacerdaDavid J. LynnHelen MarshallRoberto D. OliveiraJorge RochaAlice SawkaFernando ValLaure F. PittetNicole L. MessinaNigel Curtisa Departm Source Type: research
Parental intention on getting children COVID-19 vaccinations: Invariance evaluation across parenting roles and COVID-19-like symptoms experiences among Iranians during the pandemic period
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 6, 2024 Category: Allergy & Immunology Authors: Daniel Kwasi AhorsuMarc N. PotenzaChung-Ying LinAmir H. Pakpoura Department of Special Education and Counselling, The Education University of Hong Kong, Tai Po, Hong Kongb Departments of Psychiatry and Neuroscience and the Child Study Center and Wu Tsai I Source Type: research
Introduction of the pneumococcal conjugate vaccine in humanitarian and fragile contexts: Perspectives from stakeholders in four African countries
Volume 20, Issue 1, December 2024 . (Source: Human Vaccines and Immunotherapeutics)
Source: Human Vaccines and Immunotherapeutics - March 5, 2024 Category: Allergy & Immunology Authors: Baldeep K. DhaliwalRose WeeksJasmine HuberAminata FofanaMohamed BobeAntoinette Demian MbailamenGeorge LeggeGassim CisseAnita Sheta International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Ba Source Type: research